The Use of Intravitreal Ranibizumab for Choroidal Neovascularization Associated with Vogt-Koyanagi-Harada Syndrome

Purpose. To describe the use of intravitreal ranibizumab for choroidal neovascular membrane (CNVM) secondary to Vogt-Koyanagi-Harada (VKH) syndrome. Methods. Interventional case report. Results. A 50-year-old woman presented with conjunctival injection and bilateral eye pain. Vision was 20/400 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolomeyer, A. M., Roy, M. S., Chu, D. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151517/
https://www.ncbi.nlm.nih.gov/pubmed/21826150
http://dx.doi.org/10.1155/2011/747648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151517/
https://www.ncbi.nlm.nih.gov/pubmed/21826150
http://dx.doi.org/10.1155/2011/747648

Ejemplares similares